X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Ranbaxy Laboratories Ltd.- (Amalgamation)
BSE CODE: 500359   |   NSE CODE: NA   |   ISIN CODE : INE015A01028   |   01-Apr-2015 Hrs IST
BSE NSE
Rs. 859.90
0 ( 0% )
 
Prev Close ( Rs.)
859.90
Open ( Rs.)
814.90
 
High ( Rs.)
869.00
Low ( Rs.)
810.30
 
Volume
308222
Week Avg.Volume
140309
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
2214969
 
52 WK High-Low Range(Rs.)
Particulars Mar 2014Dec 2012Dec 2011Dec 2010Dec 2009
Operational & Financial Ratios          
   Earnings Per Share (Rs)-20.76  -3.84  -72.32  27.28  13.61  
   CEPS(Rs)-14.15  0.56  -65.83  32.71  17.13  
   DPS(Rs)0.00  0.00  0.00  2.00  0.00  
   Book NAV/Share(Rs)25.42  44.93  45.32  121.63  94.03  
   Tax Rate(%)-3.60  1.18  -0.11  26.61  46.14  
Margin Ratios          
   Core EBITDA Margin(%)-4.70  7.00  13.74  21.62  13.44  
   EBIT Margin(%)-4.36  2.10  -35.17  28.47  22.96  
   Pre Tax Margin(%)-12.28  -2.59  -38.99  27.52  22.13  
   PAT Margin (%)-12.72  -2.56  -39.04  20.20  11.92  
   Cash Profit Margin (%)-8.67  0.38  -35.53  24.21  15.01  
Performance Ratios          
   ROA(%)-5.98  -1.09  -21.20  9.42  5.34  
   ROE(%)-59.07  -8.52  -86.78  25.32  15.28  
   ROCE(%)-4.30  2.04  -35.14  19.19  14.79  
   Asset Turnover(x)0.47  0.43  0.54  0.47  0.45  
   Sales/Fixed Asset(x)2.04  2.01  2.66  2.08  1.92  
   Working Capital/Sales(x)-2.00  -5.63  -4.54  1.44  3.92  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.49  0.50  0.38  0.48  0.52  
   Receivable days70.62  147.54  116.14  90.72  97.35  
   Inventory Days90.52  97.63  73.42  87.29  92.40  
   Payable days129.28  162.63  181.62  191.66  175.07  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  21.94  38.03  
   PCE(x)-25.81  892.54  -6.16  18.30  30.21  
   Price/Book(x)14.36  11.19  8.94  4.92  5.50  
   Yield(%)0.00  0.00  0.00  0.33  0.00  
   EV/Net Sales(x)3.04  3.69  2.50  4.72  5.09  
   EV/Core EBITDA(x)45.28  33.19  15.04  16.79  19.49  
   EV/EBIT(x)-69.17  175.11  -7.09  16.52  22.11  
   EV/CE(x)1.41  1.59  1.29  1.96  2.26  
   M Cap / Sales2.25  3.37  2.19  4.45  4.55  
Growth Ratio          
   Net Sales Growth(%)8.91  -19.18  37.56  18.60  6.93  
   Core EBITDA Growth(%)-34.25  -46.01  -18.61  27.50  194.75  
   EBIT Growth(%)-327.11  104.83  -269.79  47.04  174.76  
   PAT Growth(%)-441.46  94.68  -365.69  100.83  154.75  
   EPS Growth(%)-440.93  94.69  -365.09  100.54  154.74  
Financial Stability Ratios          
   Total Debt/Equity(x)5.75  2.53  2.27  0.83  0.85  
   Current Ratio(x)0.65  0.87  0.82  1.93  1.33  
   Quick Ratio(x)0.48  0.67  0.65  1.59  1.00  
   Interest Cover(x)-0.55  0.45  -9.20  29.88  27.91  
   Total Debt/Mcap(x)0.40  0.23  0.25  0.17  0.15